Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Therapeutics    source : Alteritytherapeutics.com    save search

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Published: 2024-04-17 (Crawled : 01:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 7.32% C: -1.95%

disease neurology system meeting parkinson’s therapeutics
Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
Published: 2024-04-09 (Crawled : 23:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 22.28% C: 13.47%

ath434 drug congress world therapeutics usa
Alterity Therapeutics Receives a $3.9 million Research & Development Tax Incentive Refund
Published: 2024-03-26 (Crawled : 04:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 2.34% H: 5.11% C: 2.86%

million research therapeutics
Alterity Therapeutics Raises $3.25 M AUD in Placement
Published: 2024-02-22 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: -11.76% H: 5.56% C: -5.0%

therapeutics
Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
Published: 2024-02-20 (Crawled : 02:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: -1.96% H: 4.0% C: 1.5%

meeting therapeutics
Alterity Therapeutics Successfully Completes Securities Purchase Plan (SPP)
Published: 2024-02-01 (Crawled : 23:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -2.35%

therapeutics
Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
Published: 2024-02-01 (Crawled : 05:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 6.16% H: 0.0% C: -4.91%

week therapeutics
Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
Published: 2024-01-21 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 1.08% H: 3.19% C: -1.6%

pipeline key therapeutics
Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
Published: 2023-12-04 (Crawled : 06:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 156.02% H: 27.29% C: -1.18%

ath434 therapeutics
Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
Published: 2023-12-03 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 156.02% H: 27.29% C: -1.18%

ath434 disease positive parkinson’s therapeutics
Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
Published: 2023-11-27 (Crawled : 05:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: -7.03% H: 0.58% C: 0.58%

biomarker presentation system therapeutics
Alterity Therapeutics Raises $4.8M AUD in Placement
Published: 2023-11-22 (Crawled : 06:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

therapeutics
Alterity Therapeutics Announces Presentation of New Data Demonstrating Novel Mechanisms of ATH434
Published: 2023-11-15 (Crawled : 23:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: -2.0% H: 0.56% C: -2.08%

ath434 presentation therapeutics
Alterity Therapeutics Completes Enrolment in ATH434-201 Phase 2 Clinical Trial in Multiple System Atrophy
Published: 2023-11-07 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 5.96% H: 8.43% C: 6.43%

ath434 system trial therapeutics phase 2
Alterity Therapeutics Presents New Data on Multiple System Atrophy, a Rare Parkinsonian Disorder
Published: 2023-08-31 (Crawled : 01:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.0% C: -1.09%

rare system therapeutics
Alterity Therapeutics Granted New Composition of Matter Patent in Europe for Neurodegenerative Diseases including Parkinson’s and Alzheimer’s
Published: 2023-08-23 (Crawled : 05:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 2.14% H: 0.0% C: -2.09%

europe patent granted alzheimer’s parkinson’s therapeutics neurodegenerative
Alterity Therapeutics Rare Disease Natural History Study to be Featured at the International Congress of Parkinson’s Disease and Movement Disorders
Published: 2023-08-22 (Crawled : 08:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.93% C: 3.7%

rare disease natural international disorders parkinson’s therapeutics study
Alterity Therapeutics Receives a $4.74 million Research & Development Tax Incentive Refund
Published: 2023-08-15 (Crawled : 02:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.0% C: -2.44%

research therapeutics
Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned
Published: 2023-07-26 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 2.89% H: 5.8% C: 3.5%

trial therapeutics phase 2
Alterity Therapeutics to Present in MST Access Rare Diseases, Rich Returns Forum on 22 June 2023
Published: 2023-06-21 (Crawled : 00:00) - alteritytherapeutics.com
ATHE | $2.13 0.47% 33K twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 0.0% C: -1.72%

rare mst therapeutics
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M twitter stocktwits trandingview |

AGBA | $2.97 137.6% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.59 75.27% 41.8% 2M twitter stocktwits trandingview |

ZAPP | $4.44 50.2% 33.12% 370K twitter stocktwits trandingview |
n/a

MTC | $2.24 43.59% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.045 35.33% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.33 30.39% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.5 25.0% 21.88% 280K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.